Futuristic Hospitals INVESTORS: Medical Devices, Psilocybin, Depression

Medical technology has come a long way in treating mental health issues. But what role do the investors play in all of this? This “Your Voice is Amplified” podcast episode summarizes how investors have impacted medical technology and how investment in this area can help treat prevailing depressive disorders on a global level. Significant investments to date in psilocybin trials include UK- based pharmaceutical firm Compass Pathways. Australia has already invested more than $3 million to study the effects of these trials.